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ABSTRACT

69

Background and Purpose: An ischemic stroke occurs when blood flow to an area of the brain is

70

restricted and can cause numbness or weakness on one side of the body, facial droop, trouble speaking,

71

and trouble walking. Patients who seek medical attention for symptoms within three hours of their onset

72

can be eligible to receive tissue plasminogen activator (tPA). These patients often have less resultant

73

disability than their counterparts who did not receive the drug. The purpose of this case reports is to

74

display the positive effects of tPA and physical rehabilitation following a stroke in the acute care setting.

75

Case Description: The patient was an 83-year-old Caucasian female with an acute right thalamic

76

stroke and complaints of left sided weakness with numbness and tingling. tPA was administered within

77

one hour of symptom onset. Strength, sensation, coordination, and functional mobility were evaluated

78

before and after the administration.

79

Outcomes: The patient in this case report showed improvements in strength (grossly 2-/5 to 4-/5),

80

sensation (numbness to intact), and coordination (unable to perform to slowed and decreased accuracy) as

81

a result of tPA administration following a stroke. The patient was discharged home with minor

82

impairments in functional mobility.

83

Discussion: This case report demonstrates the importance of early stroke symptom recognition so

84

that eligible patients can receive tPA to decrease impairments and to have better outcomes in the area of

85

functional mobility.

86

Word count: 222

87
88

BACKGROUND and PURPOSE

89

An ischemic stroke occurs when blood flow to an area of the brain is restricted 1. Stroke

90

is the fifth leading cause of death in the U.S. and kills 140,000 each year2. Symptoms of stroke

91

include sudden numbness or weakness on one side of the body, facial droop, trouble speaking,

92

and trouble walking. Patients who seek medical attention for symptoms within 3 hours of their

93

onset can be eligible to receive tissue plasminogen activator (tPA). With ischemic strokes, tPA
3
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works by dissolving the blood clot to enhance blood flow in the brain which helps decreases the

95

damage caused by the stroke. Patients who receive tPA within 3 hours often have less resultant

96

disability than their counterparts who did not receive the drug3.

97

Pharmacological and physical therapy interventions are important to reduce effects of

98

stroke. Patients affected by stoke can display decreased strength, decreased balance, numbness

99

and/or tingling, ataxia, flaccidity, spasticity, inattention or neglect, visual changes, and speech

100

disturbances4. While tPA targets the area of the brain affected by the stroke to help decrease

101

these impairments, physical therapy is important to help the patient regain their functional

102

mobility and independence. The purpose of this case reports is to display the positive effects of

103

tPA and physical rehabilitation following a stroke in the acute care setting.

104
105
106
107

CASE DESCRIPTION

108

year-old Caucasian female suspected to have had a cerebrovascular accident (CVA). The patient

109

presented to the emergency department with complaints of a stroke-like symptoms with sudden

110

onset at 18:00 that day. The patient reported she was eating dinner with her husband when he

111

noticed the patient had a left facial droop. The patient also experienced numbness and tingling in

112

her left foot and reported her throat felt like it was closing. Upon emergency medical service

113

(EMS) arrival, she had a severe left sided facial droop and her left side was completely flaccid.

114

tPA was administrated at the hospital at 18:50. Magnetic resonance imaging (MRI) carried out

115

24 hours after the administration of tPA confirmed an acute right thalamic CVA. See Figure 1

116

for MRI.

Patient History
The patient provided written consent to participate in this case report. The patient was an 83-

117

The patient’s past medical history included hypertension and lipidemia, which she was

118

controlling with medications. See Appendix 1 for full list of medications. No significant or
4
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relevant surgical history was deemed to interfere with tPA or physical therapy intervention. The

120

patient stated that she would like to return to her prior level of function (PLOF) with the help of

121

physical therapy.

122
123

Systems Review
A systems review was performed in the emergency department before and after tPA was

124

administered. Overall, all systems were impaired before and after tPA administration; but

125

improvements in the musculoskeletal and neuromuscular systems were evident after the tPA was

126

administered. See Table 1 for systems reviews.

127
128
129

Clinical Impression

130

The differential diagnoses, before the MRI confirmation, included cardioembolic stroke, small

131

vessel disease/lacune, thromboembolic, hypercoagulable state-related infarct, and transient

132

ischemic attack. Physical therapy was determined necessary to address impairments in areas such

133

as strength, sensation, coordination, and gait. The patient was a good candidate for this case

134

report as she was motivated to return to her PLOF and was compliant with all medical and

135

therapy inventions.

136
137

Examination – Tests and Measures
The patient was agreeable to a physical therapy examination that included strength,

138

sensation, coordination, and functional mobility assessment. Manual Muscle Testing (MMT) of

139

myotomes C5-C8, L2-L4, and S1-S2 was performed with patient sitting at the edge of the bed

140

and graded by the system adopted by Kendall5. Light touch of dermatomes L2-L5 and S1 was

141

assessed. Coordination of upper and lower extremities was tested using rapid alternating

142

movements (RAMs), finger to nose test with increasing speed and eyes closed, and heel to shin

143

test. Bed mobility, transfers, and ambulation were also assessed during the initial examination6.

144

Refer to Table 2 for findings.

The patient’s primary complaint was left sided weakness with numbness and tingling.

5
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146

Outcome Measures
A variety of outcome measures were used to assess the patient’s progress over the course

147

of the hospital stay. The National Institution of Health (NIH) Stroke Scale is used with patients

148

that have suffered an acute ischemic stroke, hemorrhagic stroke, or transient ischemic attack. It

149

assesses acute status, treatment efficacy, and helps predict outcomes. It is only used when the

150

patient is initially assessed. The scale has a high reliability and validity when used by providers

151

who use the scale on a daily basis7. The patient scored a 6 on the NIH scale at admission, which

152

is indicative of a mild stroke.

153

The Modified Rankin Handicap Scale compares the patient’s functional independence

154

after suffering a stroke to his/her pre-stroke function. Scores are determined based on how the

155

patient performs activities of daily living (ADLs), their neurological deficits, and other aspects of

156

their life. For the stroke population it has an excellent test-retest reliability and inter-rated and

157

intra-rated reliability8. The patient was determined to score a 0 (no symptoms or disability)

158

before admission, and a 1 (no significant disability despite symptoms) at discharge.

159

The Activity Measure for Post-Acute Care (AM-PAC) "6-Clicks" Inpatient Short Forms

160

uses 6 questions to assess functional outcomes of patients in post-acute care settings. It measures

161

difficulty, assistance, and limitations in mobility and/or ADLs. It also helps predict discharge. It

162

has a high test-retest reliability and interrater reliability between medical professionals. There is

163

no validity reported for this outcome measure. The patient received 3’s in all parts of the

164

mobility domain at both evaluation and discharge, which suggested that the patient would need

165

“a little” help with the mobility activities and had a 40.47% decrease in function 9. Refer to Table

166

3 for results and interpretation of all outcome measures for this patient.

167

Clinical Impression: Evaluation, Diagnosis, Prognosis

168

The patient presented to the emergency department with left facial droop, left side
6
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weakness, and left lower extremity numbness. The patient and spouse were able to identify

170

symptoms immediately and sought medical attention. The medical team was able to administer

171

tPA within one hour of symptom onset. An MRI confirmed that the patient experienced an acute

172

right thalamic stroke. The patient was agreeable to further medical treatment and physical

173

therapy interventions. At the time of physical therapy evaluation, the patient presented with left

174

side weakness, impaired coordination of the left upper and lower extremities, and gait

175

abnormalities; but the symptoms had improved from the initial evaluation in the emergency

176

room. The patient also agreed that she already noticed improvement of symptoms since tPA

177

administration.

178

The medical diagnosis was determined to be cerebral infarction (I63.9). The physical

179

therapy diagnoses included hemiparesis (I69.354) and ataxia following cerebral infarction

180

(I69.393). The patient had a good prognosis with physical therapy. The patient was able to

181

receive tPA within the most effective window10, and prior to tPA, she had been exercising 3 days

182

a week, had a supportive spouse and family, and she was motivated to return to her prior level of

183

function11. The patient also had an initial NIH Stroke Scale score of 6 before tPA and her

184

symptoms improved after. A NIH score of <5 is a strong predictor of being discharged home12.

185

Occupational therapy and speech therapy were also consulted as part of the stroke team.

186

Patient was scheduled for a right carotid endarterectomy (CEA) three days after physical therapy

187

evaluation. See Figure 2 for a description of the surgery. The patient received a physical therapy

188

treatment by a physical therapy assistant before the surgery to prevent deconditioning. A

189

physical therapy re-evaluation was ordered and performed 1-day post-operation to determine

190

further needs for the patient once discharged. After the re-evaluation, it was recommended that

191

the patient receive home health physical therapy (HHPT) to improve strength, balance,

192

coordination, and mobility. Short-term goals for the patient were developed. Refer to Table 4 for
7
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specific goals.

194

Intervention and Plan of Care

195

Before performing the initial evaluation with the patient, the student physical therapist

196

(SPT) performed a record review. The SPT consulted the patient’s nurse to receive any other

197

updates in the patient’s care and status. An evaluation that involved a patient history, assessed

198

strength, sensation, coordination, bed mobility, transfers, and gait was carried out. After the

199

evaluation, important information about the patient’s performance and further recommendations

200

for therapy were relayed to the nurse. All information gathered by the SPT was recorded in the

201

electric medical record system, EPIC. The patient was also evaluated by occupational and speech

202

therapy, but therapy was not indicated. The patient was informed by the medical team that she

203

was eligible for a right CEA to remove plaque in the carotid artery to decrease her risk of future

204

stroke. The patient was agreeable to surgery and participated in a physical therapy treatment

205

session with a physical therapy assistant (PTA) to prevent deconditioning and learn new

206

movement strategies prior to surgery. The session with the PTA focused on functional mobility.

207

During that session the PTA had the hospital bed mimic the patient’s bed at home (i.e. head of

208

bed flat, height of bed, railings down) and gave instruction for rolling, performing supine to sit,

209

and sit to supine. The PTA gave verbal cues and broke the task down into parts as needed. The

210

patient was educated on momentum strategies and limb and trunk positioning to make bed

211

mobility the most effective. The patient also practiced transfers from surfaces that most closely

212

mimic the patient’s home environment (i.e. height of bed, height of chair, height of toilet). The

213

PTA educated the patient on “nose over toes” and pushing up with arms from the surface instead

214

of on other objects in the room. Again, the PTA gave verbal cues and broke the task down into

215

parts as needed. To end the session the patient ambulated in the halls. The PTA gave feedback

216

for heel strike, arm swing, and posture and recorded the distance ambulated. The patient did not
8
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require an assistive device during the treatment session. A physical therapy re-evaluation was

218

performed after the surgery to determine if there were any further impairments that required

219

discharge recommendations. Refer to Table 5 for specific interventions.

220

Timeline

221

222

223
224
225

Outcomes
The patient in this case report showed improvements in strength, sensation, and

226

coordination as a result of tPA administration following a stroke. The patient was discharged

227

home with HHPT and minor impairments in functional mobility. Follow-up in the neurologist’s
9
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office was scheduled. It is likely that her good outcomes following her stroke were because she

229

was able to recognize the symptoms at onset, sought appropriate medical attention, did not

230

smoke, exercised regularly, and participated in all physical therapy and medical interventions.

231

Refer to Table 6 for detailed outcomes.

232

Discussion

233

This case report displayed how tPA decreased the impairments experienced by this

234

patient after the onset of a stroke. Table 2 which compares the systems review both before and

235

after tPA was administered. The improvements seen at that time were maintained throughout the

236

patient’s hospital and stay a CEA procedure. The patient was able to be discharged home and

237

receive HHPT.

238

The effects observed in this case are consistent with the literature that states that tPA

239

received within 3 hours of symptom onset reduces impairments. Additionally, this patient had

240

several positive prognostic indicators. These factors yield a good prognosis after stroke, so it is

241

difficult to determine whether her positive outcome was solely impacted by the tPA, and thus

242

limiting the generalizability of this study. Perhaps this patient would have regained most of her

243

function without receiving the prompt medical attention that she did. Future case reports

244

including patients with poor prognostic factors may enhance the literature that supports the use

245

of tPA.

246

The strengths of this case included the thorough documentation and prompt medical

247

attention provided by all members of this patient’s healthcare team. The testing and re-testing of

248

systems and function were performed in a timely manner so that outcomes were accurate. In

249

conclusion, this case report demonstrates the importance of early stroke symptom recognition in

250

order to receive tPA to decrease functional impairments and to have better outcomes with

251

physical therapy.
10
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TABLES and FIGURE

299

Table 1 Systems Review in Emergency Department
System
Before tPA
Cardiovascular/Pulmonary CTA scan of neck:
70% diameter reduction of the right
carotid artery
50% diameter reduction of the left
carotid artery
Musculoskeletal
Left UE Strength: Grossly 2+/5
Left LE Strength: Grossly 3/5
Neuromuscular
Left facial droop

Integumentary
Communication
Affect, Cognition,
Language, Learning Style

After tPA
Unchanged

Left UE Strength: Grossly 4-/5
Left LE Strength: Grossly 4-/5
Facial droop absent

Finger-to-nose:
Intact on right
Unable to perform on left

Finger-to-nose:
Intact on right
Slow and decreased accuracy
on left

Numbness/tingling in left lower
extremity
Clammy and diaphoretic
Slight slurred speech
Alert and orientated to person,
place, and time

Light touch: intact throughout

300

*CTA= Computed tomography angiography

301

* UE= Upper Extremity

302

* LE= Lower Extremity

303
304
305
306
307
308
309
310
12

Intact
Intact
Alert and oriented to person,
place, time, situation
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Table 2 Tests and Measures during Initial Evaluation
Tests & Measures
Manual Muscle
Testing
Sensation
Coordination

Initial Evaluation Results
Right UE Grossly 5/5
Right LE Grossly 5/5
Left UE Grossly 4-/5
Left LE Grossly 4-/5
Light touch intact throughout but hypersensitivity left lateral thigh
RAMs:
Intact on right upper and lower extremities
Decreased speed and slight delay on left UE and LE
Finger-to-nose:
Intact on right
Slow and decreased accuracy on left

Bed Mobility
Transfers
Gait analysis

Heel-to-shin:
Intact on right
Slow and decreased accuracy on left
The patient required supervision for rolling, supine to sit, sit to
supine, and scooting activities with HOB elevated and use of
handrails
The patient required minimal assistance to perform transfers from
bed to chair and chair to bed.
The patient required minimal assistance on the right side with a
hand-held assist for ambulation. The patient was able to walk 450
feet with a 30 second standing rest break due to fatigue. The patient
demonstrated a flat foot on the left, slight genu recurvatum on the
left when fatigued, and scissoring gait during dual tasks.

312

*UE= Upper Extremity

313

*LE= Lower Extremity

314

*RAMS= Rapid Alternating Movements

315

* HOB= Head of Bed

316
317
318
319
320
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Table 3 Outcome Measures
Outcome Measures
NIH Stroke Scale
Before tPA

Modified Rankin
Scale

AM-PAC “6 clicks”
Basic Mobility
Domain

Results

NIH Stroke Scale
Level of Consciousness (LOC) = 0
LOC Question = 0
LOC Commands = 0
Best Gaze = 0
Visual = 0
Facial Palsy = 0
Motor Arm - Left = 1
Motor Arm - Right = 0
Motor Leg - Left = 1
Motor Leg - Right = 0
Limb Ataxia = 2
Sensory = 2
Best Language = 0
Dysarthria = 0
Extinction and Inattention = 0

NIH Stroke Scale Score = 6 (mild stroke)
0 No symptoms at all: Before Admission
1 No significant disability despite symptoms; able to carry out all
usual duties and activities: At Discharge
2 Slight disability; unable to carry out all previous activities, but able
to look after own affairs without assistance
3 Moderate disability; requiring some help, but able to walk without
assistance
4 Moderately severe disability; unable to walk without assistance
and unable to attend to own bodily needs without assistance
5 Severe disability; bedridden, incontinent and requiring constant
nursing care and attention
6 Dead
At evaluation and discharge:
Bed mobility- 3
Sit to stand; stand to sit- 3
Supine to sit- 3
Seated transfers- 3
Ambulation- 3
Ascending stairs- 3
40.47% decrease in function

322
323
14

Scoring related to difficulty:
1 = Total; dependent
2 = A lot; maximum or moderate
assistance
3 = A little; minimum assistance,
contact guard assistance,
supervision
4 = None; no human assistance
needed
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Table 4 Goals
Short Term Goals
1. Patient will perform all bed mobility safely, independently, and with no assistance or cueing.
2. Patient will perform all transfers with supervision and no assistive device
3. Patient will ambulate 500 ft with supervision and no assistive device with stable vital signs.

325

Table 5 Interventions
Evaluation (after tPA)
Bed mobility
Assessed how the patient
Purpose:
rolled, performed supine
functional mobility to sitting, sitting to
supine, and scooting.
Manual Muscle
Testing
Purpose: track
progress
Sensation
Purpose: track
progress
Coordination
Purpose: track
progress

Myotomes C5-C8 and
L2-L4 and S1-S2

Rx
Log rolling to left and
right x5 each
Supine < > sit x5
Sit < > supine x5
N/A

Light touch L2-L5 and
S1

N/A

Finger-to-nose test, heelto-shin test, rapid
alternating movements of
upper and lower
extremities.

N/A

Transfers
Transfers to and from
Purpose:
bed, chair, and toilet.
functional mobility

Sit < > stand bed x5
Sit< > stand chair x5

Sit < > stand toilet x5
Gait
Assessed gait pattern of
Ambulated in halls
Purpose:
patient. Recorded the
500 feet with focus on
functional mobility distance ambulated by the quality of gait
patients and any
impairments of gait.

15

Re-evaluation (after CEA)
Assessed how the patient
rolled, performed supine to
sitting, sitting to supine, and
scooting. Compared
changes, if any, from initial
evaluation.
Myotomes C5-C8 and L2L4 and S1-S2.
Compared changes, if any,
from initial evaluation.
Light touch of L2-L5 and
S1. Compared changes, if
any, from initial evaluation.
Finger-to-nose test, heel-toshin test, rapid alternating
movements of upper and
lower extremities. Compared
changes, if any, from initial
evaluation.
Transfers to and from bed,
chair, and toilet. Compared
changes, if any, from initial
evaluation.
Assessed gait pattern of
patient. Recorded the
distance ambulated by the
patients and any
impairments of gait.
Compared changes, if any,
from initial evaluation.
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Vital Signs
Purpose: ensure pt
is responding well
to therapy

326
327

Assessed heart, oxygen
saturation, and blood
pressure of patient as
patient became
symptomatic and at end
of session and reported to
nurse.

Assessed heart, oxygen
saturation, and blood
pressure of patient as patient
became symptomatic and at
end of session and reported
to nurse.

Table 6
Outcomes
Strength

Sensation

Before tPA
Left UE Strength: Grossly
2+/5
Left LE Strength: Grossly
3/5
Numbness/tingling in left
lower extremity

Coordination

Failed finger-to-nose test
on left

Bed mobility

Not tested-was independent
before admission
Not tested- was
independent before
admission
Not tested- was
independent before
admission
Not tested- 0 (no
symptoms) before
admission

Transfers
Gait
Modified Rankin Scale

AM-PAC
328
329
330
331
332
333
334
335
336
337
338
339
340
341

Assessed heart,
oxygen saturation, and
blood pressure of
patient as patient
becames symptomatic
and at end of session
and reported to nurse.

Not tested- was
independent before
admission

16

At Discharge

Left UE Strength: Grossly 4-/5
Left LE Strength: Grossly 4-/5

Light touch intact
throughout but
hypersensitivity left lateral
thigh
Slow and decreased
accuracy with finger-tonose test on left
Supervision
Supervision
Minimum Assistance
1-No significant disability
despite symptoms; able to
carry out all usual duties
and activities
40.47% decrease in function
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Figure 1 MRI
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Figure 2 CEA description
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Appendix 1 Home Medications
Home Medications
Gemfibrozil (LOPID)
Atenolol (TENORMIN)
Ezetimibe (ZETIA)
Venlafaxine XR (EFFEXOR-XR)
ASCORBIC ACID
CHOLECALCIFEROL
Sulfamethoxazole-trimethoprim
(BACTRIM DS, SEPTRA DS)

Indications
High Cholesterol
High Blood Pressure
High Cholesterol
Nerve pain or antidepressant
Low Vitamin C
Low Vitamin D
Treat/prevent infections
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CARE Checklist
Page

1.

CARE Content Area
Title – The area of focus and “case report” should appear in the title

2

2.

Key Words – Two to five key words that identify topics in this case report

2

3.

Abstract – (structure or unstructured)
a. Introduction – What is unique and why is it important?
b. The patient’s main concerns and important clinical findings.
c. The main diagnoses, interventions, and outcomes.
d. Conclusion—What are one or more “take-away” lessons?

3

4.

Introduction – Briefly summarize why this case is unique with medical literature
references.

3-4

5.

Patient Information
a. De-identified demographic and other patient information.
b. Main concerns and symptoms of the patient.
c. Medical, family, and psychosocial history including genetic information.
d. Relevant past interventions and their outcomes.

4-5, 18

6.

Clinical Findings – Relevant physical examination (PE) and other clinical findings

5-7,
12-14

7.

Timeline – Relevant data from this episode of care organized as a timeline (figure
or table).

9

8.

Diagnostic Assessment
a. Diagnostic methods (PE, laboratory testing, imaging, surveys).
b. Diagnostic challenges.
c. Diagnostic reasoning including differential diagnosis.
d. Prognostic characteristics when applicable.

7,17

9.

Therapeutic Intervention
a. Types of intervention (pharmacologic, surgical, preventive).
b. Administration of intervention (dosage, strength, duration).
c. Changes in the interventions with explanations.

8-9
15-16

10. Follow-up and Outcomes
a. Clinician and patient-assessed outcomes when appropriate.
b. Important follow-up diagnostic and other test results.
c. Intervention adherence and tolerability (how was this assessed)?
d. Adverse and unanticipated events.

9-10
16

11. Discussion
a. Strengths and limitations in your approach to this case.
b. Discussion of the relevant medical literature.
c. The rationale for your conclusions.
d. The primary “take-away” lessons from this case report.

10

12. Patient Perspective – The patient can share their perspective on their case.

N/A

19
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13. Informed Consent – The patient should give informed consent.

379
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2

